Actavis Inc

Actavis Plc (NYSE: ACT) is a unique specialty pharmaceutical company focused on developing, manufacturing and commercializing generic and innovative-branded pharmaceutical products for patients around the world. Actavis markets generic, branded-generic, legacy brands and over-the-counter (OTC) products in more than 60 countries. It also develops innovative medicines for patients suffering from diseases principally in the central nervous system, gastroenterology, women’s health, urology, cardiovascular, respiratory and anti-infective therapeutic categories. Actavis Global Operations has more than 30 manufacturing and distribution facilities around the world, with a capacity of more than 44 billion doses.